We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Celadon Pharmaceuticals Plc | LSE:CEL | London | Ordinary Share | GB00BDQYGP38 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 19.00 | 17.00 | 21.00 | 19.00 | 19.00 | 19.00 | 6,589 | 08:00:02 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 149k | -7.14M | -0.1078 | -1.76 | 12.58M |
Date | Subject | Author | Discuss |
---|---|---|---|
23/8/2024 12:36 | "Dog" is too polite and rude to dogs, which are lovely. This is a stinking cess pit of a foul smelling scam. | jaknife | |
23/8/2024 11:44 | Avoid this dog | blakesmith | |
20/8/2024 08:05 | I am presuming some finance is sorted or else it’s a scandal this has been allowed to trade as long as it has, following that RNS. | talk2dubya | |
15/8/2024 14:48 | Cannot beat a bit of death spiral financing. | talk2dubya | |
13/8/2024 11:53 | Riverfort is about to enter the scene. Enjoy !! Regards, F911 RMC | firestorm911 | |
13/8/2024 11:12 | F911 is proudly reducing the target price from 1p to 0.000911p. Good shs to short. Enjoy !! Regards, F911 RMC | firestorm911 | |
12/8/2024 08:31 | Celadon informs the market that: 1. It hasn't received all of cash from the May placing (three months after!), 2. It hasn't received the cash from the loan announced in May, and 3. It only has £48k of cash left before it's lights off time | jaknife | |
09/8/2024 13:38 | Spot on again, JakNife. | papillon | |
17/7/2024 07:55 | a 1p stock? It's a scam with fake contract. This will be joining the famous -99% club. Regards, F911 RMC | firestorm911 | |
03/7/2024 09:50 | talk2dubya, "Well the facilities alone are worth 60m. Nice update" I'm afraid that whomever told you that was taking advantage of your naivety. The accounts are quite clear: CEL has invested less than £3m into its "facilities", which are loss-making. JakNife | jaknife | |
03/7/2024 09:35 | I don’t think I have ever held a share as poor as this, in terms of shareholder engagement and newsflow. | talk2dubya | |
23/5/2024 10:14 | can't see any reason to value this at more than the book value of £3.2m, especially bearing in mind that they obviously need to raise funds again Well the facilities alone are worth 60m. Nice update | talk2dubya | |
22/5/2024 20:02 | Its funny investors keep committing money at above the market price when the vast majority have to raise at huge discounts. Somebody can see a big return here, could they be right? | czar | |
10/5/2024 06:59 | These new investors want in to CEL and are happy to pay the offer price, that speaks volumes for what they know about this business. | czar | |
07/3/2024 13:27 | Looks like a pretty significant RNS to me this. Market seems to have missed it, have bought a few today. Is this not significant, the part about the GP’s? gives us even greater confidence in our forthcoming clinical trial, which will involve up to 5,000 patients and see General Practitioners permitted to prescribe cannabis-based medicines | talk2dubya | |
12/12/2023 14:19 | This looks to be yet another UK Company that is achieving excellent progress but is massively undervalues on AIM. It has to either rerate, be taken over or move to another exchange. The last UK business with similar credentials was GW Pharma and that got bought for $7.2 billion. | czar |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions